Public recall detail

ACT Methylphenidate ER (2020-02-07)

medium
Recall Safety notice
Quick summary

Quick summary: ACT Methylphenidate ER (2020-02-07) .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: ACT Methylphenidate ER (2020-02-07) .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Affected products

DescriptionACT Methylphenidate ER 18 mg Tablet DIN, NPN, DIN-HIM DIN 02441934 Dosage form Tablet (Extended-Release) Strength Methylphenidate hydrochloride 18 mg Lot or serial number 1293319A Companies Recalling Firm Teva Canada Ltd. 30 Novopharm Court Toronto M1B 2K9 Ontario CANADA Marketing Authorization Holder Teva Canada Ltd. 30 Novopharm Court Toronto M1B 2K9 Ontario CANADA
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...